Answers are grounded in this paper and cite their sources.
Background Transdermal nicotine patches are widely used for the treatment of nicotine dependence. The abuse liability of nicotine replacement therapies is considered low because of an absence of peaks observed with smoking. While typically well-tolerated, higher doses of transdermal nicotine patches may pose risks of adverse effects, as illustrated by a case of a young adult experiencing euphoria with a 63 mg patch.
No takes yet. Share an insight, caveat, or question.
Panwar et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: